Armata Pharmaceuticals (ARMP) Total Liabilities (2016 - 2018)
Historic Total Liabilities for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q3 2018 value amounting to $3.8 million.
- Armata Pharmaceuticals' Total Liabilities fell 641.15% to $3.8 million in Q3 2018 from the same period last year, while for Sep 2018 it was $3.8 million, marking a year-over-year decrease of 641.15%. This contributed to the annual value of $3.4 million for FY2017, which is 5958.48% down from last year.
- Latest data reveals that Armata Pharmaceuticals reported Total Liabilities of $3.8 million as of Q3 2018, which was down 641.15% from $3.4 million recorded in Q2 2018.
- Armata Pharmaceuticals' Total Liabilities' 5-year high stood at $70.5 million during Q1 2014, with a 5-year trough of $3.1 million in Q1 2018.
- Moreover, its 5-year median value for Total Liabilities was $7.7 million (2017), whereas its average is $16.0 million.
- As far as peak fluctuations go, Armata Pharmaceuticals' Total Liabilities crashed by 8539.08% in 2016, and later skyrocketed by 3313.62% in 2017.
- Armata Pharmaceuticals' Total Liabilities (Quarter) stood at $23.2 million in 2014, then plummeted by 70.29% to $6.9 million in 2015, then grew by 22.37% to $8.4 million in 2016, then plummeted by 59.58% to $3.4 million in 2017, then rose by 10.54% to $3.8 million in 2018.
- Its last three reported values are $3.8 million in Q3 2018, $3.4 million for Q2 2018, and $3.1 million during Q1 2018.